‌

US Patent 11865210 Dry powder formulations and methods of use

Patent 11865210 was granted and assigned to Vectura Group on January, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Kambiz Yadidi0

Date of Patent

January 9, 2024

0

Patent Application Number

162169240

Date Filed

December 11, 2018

0

Patent Citations

US Patent 6979437 Pulmonary delivery in treating disorders of the central nervous system

0

US Patent 6994842 Aerogel powder therapeutic agents

0

US Patent 6998137 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix

0

US Patent 7025059 Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract

0

US Patent 7089934 Delivery of oral drugs

0

US Patent 7146978 Inhalation device and method

0

US Patent 7189750 Thiazole-based nitric oxide donors having at least two thiazole moieties and uses thereof

0

US Patent 7201929 Aspirin formulation for cardiovascular health

0

...

Patent Primary Examiner

0

CPC Code

0

Patent abstract

The subject technology relates generally to pulmonary delivery of NSAIDs, such as aspirin.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11865210 Dry powder formulations and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.